SCANCELL HOLDINGS PLC
SCLP | IL
Overview
Corporate Details
- ISIN(s):
- GB00B63D3314 (+2 more)
- LEI:
- 2138008RXEG856SNP666
- Country:
- United Kingdom
- Address:
- BELLHOUSE BUILDING, OX4 4GA OXFORD
- Website:
- https://www.scancell.co.uk/
- Sector:
- Consumer Discretionary
- Industry:
- Specialty Retail
Description
Scholium Group plc is a holding company specializing in rare books, works on paper, and fine art, with subsidiaries Shapero Rare Books and Shapero Modern.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-07-22 08:00 |
Earnings Release
Strong Phase 2 data on iSCIB1+ in Melanoma
|
English | 20.8 KB | |
| 2025-07-16 08:00 |
Declaration of Voting Results & Voting Rights Announcements
Share Option Exercise
|
English | 13.6 KB | |
| 2025-06-25 08:00 |
Regulatory News Service
Scancell initiates new arm in SCOPE Phase 2 study
|
English | 18.2 KB | |
| 2025-02-20 08:00 |
Directors' Dealings
Issue of share options
|
English | 41.5 KB | |
| 2025-02-17 08:00 |
Regulatory News Service
Scancell presenting at AACR IO conference
|
English | 19.6 KB | |
| 2025-01-30 08:00 |
Earnings Release
Interim Results
|
English | 250.6 KB | |
| 2025-01-23 08:00 |
Earnings Release
Notice of Interim Results
|
English | 11.5 KB | |
| 2025-01-09 08:00 |
Regulatory News Service
Modi-1 Vaccine Achieves Early Clinical Validation
|
English | 15.7 KB | |
| 2024-12-09 12:41 |
Share Issue/Capital Change
Result of Retail Offer and Total Voting Rights
|
English | 26.7 KB | |
| 2024-12-05 13:39 |
Related Party Transactions
Result of Placing and Subscription
|
English | 64.8 KB | |
| 2024-12-04 19:03 |
Capital/Financing Update
Retail Offer for up to £1 million
|
English | 31.7 KB | |
| 2024-12-04 18:59 |
Capital/Financing Update
Proposed fundraise in excess of £8.5 million
|
English | 169.9 KB | |
| 2024-12-04 08:00 |
Regulatory News Service
Second Commercial License Agreement with Genmab
|
English | 16.5 KB | |
| 2024-11-18 08:00 |
Earnings Release
Positive data from Phase 2 SCOPE trial with SCIB1
|
English | 23.2 KB | |
| 2024-10-25 16:26 |
Declaration of Voting Results & Voting Rights Announcements
Result of Annual General Meeting
|
English | 11.9 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Ampli S.A. | Poland | APL | |
|
ANEXO GROUP PLC | United Kingdom | ANX | |
|
APPLIED NUTRITION PLC | United Kingdom | APN | |
|
Automax Motors Ltd. | Israel | AMX | |
|
Bike24 Holding AG | Germany | BIKE | |
|
Bokusgruppen | Sweden | BOKUS | |
|
CAFFYNS PLC | United Kingdom | CFYN | |
|
CARD FACTORY PLC | United Kingdom | CARD | |
|
Colipays Réunion | France | MLCLP | |
|
Cybergun | France | ALCYB |